AngioSafe Peripheral CTO Crossing System Study (RESTOR-1 Study)

NACompletedINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

February 3, 2021

Primary Completion Date

April 25, 2023

Study Completion Date

June 15, 2023

Conditions
Peripheral Artery OcclusionPeripheral Arterial Disease
Interventions
DEVICE

AngioSafe Peripheral CTO Crossing System

The AngioSafe Peripheral CTO Crossing System is intended to facilitate the intraluminal placement of guidewires beyond stenotic lesions, including chronic total occlusions (CTOs) in the peripheral vasculature.

Trial Locations (18)

27518

Vascular Solutions of North Carolina, Cary

30309

Piedmont Heart Institute, Atlanta

32504

Coastal Vascular & Interventional, PLLC, Pensacola

33140

Palm Vascular Centers, Miami Beach

37660

Wellmont Cardiology Services, Kingsport

52801

Midwest Cardiovascular Research Foundation, Davenport

63128

Mercy Hospital South, St Louis

64111

Saint Luke's Hospital of Kansas City, Kansas City

70360

Cardiovascular Institute of the South, Houma

75093

Baylor Scott & White, The Heart Hospital Plano, Plano

75216

VA North Texas Medical Center, Dallas

75701

Cardiovascular Associated of East Texas, Tyler

85224

Dignity Health - Chandler Regional Medical Center, Chandler

94754

Adventist Health St. Helena, St. Helena

06820

Vascular Care Connecticut, Darien

Vascular Care Group, Wellesley

07052

American Endovascular & Amputation Prevention, West Orange

02906

The Miriam Hospital, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Veranex, Inc.

UNKNOWN

lead

AngioSafe, Inc.

INDUSTRY